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From this perspective, it is remarkable that only a small number of randomized trials have examined the effects of treatments of chronic depression. Although more than 500 randomized trials have examined the effects of psychotherapies for depression in adults, in a meta-analysis of trials of psychotherapies for chronic depression, only 16 trials were included, 7 of which were in patients with dysthymia.
1 Among the hundreds of randomized trials on selective serotonin reuptake inhibitors and tricyclic antidepressants for depression, a recent meta-analysis found only 20 trials on chronic depression, 19 of which were in patients with dysthymia. 2 A metaanalysis on combined treatments for depression, which is recommended in most treatment guidelines, included only 8 trials. 3 Considering the clinical and public health importance of chronic depression, research on this topic is needed. The study by Schramm and colleagues 4 in this issue of JAMA Psychiatry comparing the Cognitive Behavioral Analysis System of Psychotherapy (CBASP) with supportive therapy (SP) is therefore a welcome addition to the existing research on therapy for chronic depression. Several important research questions are addressed in this trial. One is whether a therapy that has been specifically developed for the treatment of chronic depression (CBASP) should be preferred instead of a nonspecific yet credible psychotherapy (SP). The CBASP is the only therapy that has been specifically developed for the treatment of chronic depression, and it seems safe to assume that this treatment is beneficial to patients, as it is found to result in good rates of response and remission, and superior effects compared with bona fide, nondirective SP. 4 An additional particular strength of the study by Schramm et al 4 is that it allowed enough length and density of treatment for psychotherapy to demonstrate an effect in the acute phase and show growing effects during almost 1 year of treatment. Like other studies, however, the study by Schramm et al 4 also leaves many important questions unanswered. Most treatment guidelines recommend a combination of pharmacotherapy and psychotherapy for treatment of chronic depression, but it is not clear which psychotherapy should be given. The CBASP would certainly be a good candidate. However, the study by Schramm and colleagues 4 was focused on monotherapy without concomitant pharmacotherapy in patients who mostly preferred psychotherapy. How CBASP, either alone or in combination, would fare in populations that preferred pharmacotherapy or combination therapy or had no preference is still not clear. Nor is the clinically more relevant question of which psychotherapy or combination would be preferable for which patients. A considerable number of head-to-head comparisons between different types of psychotherapy have shown that the effects of these different types are comparable with each other, with no or only small and nonsignificant differences. 5 Supportive therapy is an exception, with several studies showing that it is somewhat less effective than other therapies. However, this finding may be associated with the fact that SP is often used as a control condition, and may be owing to researcher allegiance, the conviction held by a researcher that a specific treatment is superior to other treatments. 6 Although CBASP is probably effective and somewhat more effective than
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